Rapid risk assessment: Dengue outbreak in Réunion, France, and associated risk of autochthonous outbreak in the EU/EEA
This update of the risk assessment ‘Dengue outbreak in Réunion, France’ published on 5 July 2018, has been triggered by the significant size of the outbreak and its expected duration, which is anticipated to overlap with high vector activity in the southern EU.
Rapid risk assessment: Chlamydia trachomatis false-negative test results by Aptima Combo 2 CT/NG assay (Hologic) in the EU/EEA, 2019
In April 2019, Finland reported false-negative or equivocal results in patients tested for Chlamydia trachomatis (CT) using Aptima Combo 2 Assay (Hologic) (AC2).
Multi-country outbreak of Listeria monocytogenes clonal complex 8 infections linked to consumption of cold-smoked fish products
This joint ECDC-EFSA rapid outbreak assessment provides an assessment of the cross-border public health risk related to L. monocytogenes infections linked to the consumption of cold-smoked fish products, possibly originating from a single food processing company.
Rapid risk assessment: Regional outbreak of New Delhi metallo-betalactamase-producing carbapenem-resistant Enterobacteriaceae, Italy, 2018–2019
A large outbreak of New Delhi metallo-beta-lactamase (NDM)-producing carbapenem-resistant Enterobacteriaceae (CRE) has been reported from the Tuscany region in Italy. Between November 2018 and May 2019, seven Tuscan hospitals notified a total of 350 cases.
Risk assessment: Who is at risk of measles in the EU/EEA?
A large epidemic of measles has affected the EU/EEA Member States in the past three years, with 44 074 cases reported to ECDC by 30 Member States between 1 January 2016 and 31 March 2019.
Rapid risk assessment: Ebola virus disease outbreak in North Kivu and Ituri Provinces, Democratic Republic of the Congo – fourth update
This is the fourth update of a rapid risk assessment originally produced on 9 August 2018. This rapid risk assessment addresses the public health risk associated with the current Ebola virus outbreak in the DRC and its implications for EU/EEA citizens. It was triggered by an increase of EVD transmission in the affected areas over recent weeks, the persistent occurrence of new cases among contacts unknown at the time of EVD diagnosis, the occurrence of a substantial number of cases outside of the ring vaccination contacts and current challenges for the prevention and control of EVD.
Zika virus transmission worldwide
Since the epidemic in the Americas peaked in the early spring of 2016, a continuous decline in the number of reported Zika virus disease cases has been observed in the majority of countries throughout the Americas and the Caribbean.
Rapid Risk Assessment: Cyclone Idai - risk of communicable diseases in southern Africa
Surveillance of infectious diseases in the aftermath of a cyclone is important for the early detection and confirmation of outbreaks. Consideration should be given to setting up a syndromic surveillance alert system if there is a need to reinforce surveillance capacity. Laboratory capacity should be assessed for confirming outbreaks of infectious diseases; if required, a referral mechanism can be established for testing samples of epidemic-prone diseases.
Rapid outbreak assessment: Multi-country outbreak of Salmonella Poona infections linked to consumption of infant formula
This document provides an assessment of the cross-border public health risk related to the outbreak of Salmonella Poona infections in infants and young children linked to consumption of infant formula.
Rapid risk assessment: Outbreak of VIM-producing carbapenem-resistant Pseudomonas aeruginosa linked to medical tourism to Mexico
This outbreak of Verona integron-encoded metallo-beta-lactamase-producing carbapenem-resistant Pseudomonas aeruginosa (VIM-CRPA) surgical site infections, related to invasive procedures performed in healthcare facilities in Tijuana, Baja California, Mexico, highlights the risks associated with medical tourism for patients and healthcare systems in the countries of origin.